- Home
- TEX vs CPRX Comparison
TEX vs CPRX Comparison
Compare TEX & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEX | CPRX |
|---|---|---|
| Founded | 1933 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.9B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | TEX | CPRX |
|---|---|---|
| Price | $61.56 | $24.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $58.50 | $33.25 |
| AVG Volume (30 Days) | 1.1M | ★ 1.1M |
| Earning Date | 02-12-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | N/A | ★ 44.94 |
| EPS | ★ 2.34 | 1.71 |
| Revenue | ★ $5,344,000,000.00 | $578,196,000.00 |
| Revenue This Year | $7.02 | $19.87 |
| Revenue Next Year | $3.97 | $7.06 |
| P/E Ratio | $25.80 | ★ $14.12 |
| Revenue Growth | 4.60 | ★ 25.56 |
| 52 Week Low | $31.53 | $19.05 |
| 52 Week High | $62.23 | $26.58 |
Technical Indicators
Market Signals| Indicator | TEX | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 68.88 | 62.29 |
| Support Level | $58.23 | $22.33 |
| Resistance Level | $62.13 | $23.31 |
| Average True Range (ATR) | 1.97 | 0.77 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 90.04 | 95.47 |
Price Performance
Historical ComparisonAbout TEX Terex Corporation
Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).